Cost should never be a barrier when patients need genetic testing. That’s why it’s Myriad’s promise to make testing accessible and affordable.
For patients who undergo myRisk testing, 97% of private insurance companies have coverage for hereditary cancer testing
At Myriad, we understand that each situation is unique. Therefore, we have designed programs to make sure testing is affordable for everyone.
Through excellent insurance and financial assistance, 75% of patients who undergo myRisk testing pay $0 and 90% of patients pay $100 or less.
It’s Myriad’s promise and commitment to provide patients with access to accurate and affordable genetic results.